Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6808 stock hub

TPEX/6808 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6808is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6808

In the news

Latest news · TPEX/6808

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E37

P25 14.4P50 18P75 31.9

ROE7

P25 -16.2P50 0.3P75 9.8

ROIC7.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6808 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

TWD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	43
Employees Change	10%
Employees Change Percent	30.3
Enterprise value	TWD 2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006808009
Last refreshed	2026-05-10
Market cap	TWD 2.4B
Price	TWD 30.65
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6808
Website	https://www.3dglobalbiotech.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.78%
EV Earnings	29.55x
EV/EBIT	47.42x
EV/EBITDA	28.49x
EV/FCF	18.77x
EV/Sales	9.51x
FCF yield	4.37%
P/B ratio	2.43x
P/E ratio	37.02x
P/S ratio	11.58x
PE Ratio3 Y	51.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.05%
EBITDA Margin	28.13%
FCF margin	50.66%
Gross margin	71.79%
Gross Profit	TWD 148.4M
Gross Profit Growth	-34.21%
Gross Profit Growth Q	-54.54%
Gross Profit Growth3 Y	61.3%
Gross Profit Growth5 Y	105.38%
Net Income	TWD 66.5M
Net Income Growth	-27.45%
Net Income Growth Q	-72.1%
Net Income Growth Years	0%
Pretax Margin	25.3%
Profit Margin	32.18%
Profitable Years	2
ROA	2.43
Roa5y	-3.95
ROCE	3.95
ROE	7.04
Roe5y	-5.71
ROIC	7.46
Roic5y	-13.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.35%
Cagr3y	3.69%
Cagr5y	-5.28%
EPS Growth	-35.39
EPS Growth Q	-72.63
EPS Growth Years	0
FCF Growth	602.5%
FCF Growth Q	95.97%
OCF Growth	464.35%
OCF Growth Q	70.38%
Revenue Growth	-22.19x
Revenue Growth Q	-53.21x
Revenue Growth Years	0x
Revenue Growth3 Y	55.34x
Revenue Growth5 Y	65.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.19
Assets	TWD 1.1B
Cash	TWD 477.2M
Current Assets	TWD 574.5M
Current Liabilities	TWD 40.8M
Debt	TWD 48.7M
Debt EBITDA	TWD 0.71
Debt Equity	TWD 0.05
Debt FCF	TWD 0.46
Equity	TWD 984.5M
Interest Coverage	29.59
Liabilities	TWD 106.1M
Long Term Assets	TWD 516.1M
Long Term Liabilities	TWD 65.3M
Net Cash	TWD 428.6M
Net Cash By Market Cap	TWD 17.9
Net Cash Growth	-30.77%
Net Debt EBITDA	TWD -7.37
Net Debt Equity	TWD -0.44
Net Debt FCF	TWD -4.09
Tangible Book Value	TWD 911.4M
Tangible Book Value Per Share	TWD 11.84
WACC	5.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.08
Inventory Turnover	3.96
Net Working Capital	TWD 63.5M
Quick ratio	13.49
Working Capital	TWD 533.7M
Working Capital Turnover	TWD 0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.92%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	TWD 0.1
Dividend Years	1
Dividend Yield	0.32%
Last Dividend	TWD 0.53
Payout Ratio	62.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.33%
200-day SMA	43.91
3Y total return	11.48%
50-day SMA	34.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-23.74%
All Time High	76
All Time High Change	-59.67%
All Time High Date	2020-12-25
All Time Low	17.2
All Time Low Change	78.2%
All Time Low Date	2023-10-11
ATR	1.79
Beta	0.3
Beta1y	-0.08
Beta2y	0.15
Ch YTD	-36.54
High	31.3
High52	63
High52 Date	2025-10-27
High52ch	-51.35%
Low	29.4
Low52	29.4
Low52 Date	2026-05-08
Low52ch	1.66%
Ma50ch	-11.35%
Price vs 200-day SMA	-30.2%
RSI	40.86
RSI Monthly	39.5
RSI Weekly	33.62
Sharpe ratio	-1.04x
Sortino ratio	-1.55
Total Return	-11.6%
Tr YTD	-36.54
Tr1m	-8.51%
Tr1w	-7.26%
Tr3m	-27.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 41.5M
Operating Income Growth	-67.35
Operating Income Growth Q	-92.35
Operating margin	20.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,531,663%
Net Borrowing	-10,292,000
Shares Insiders	27.88%
Shares Institutions	3.25%
Shares Out	76,982,000
Shares Qo Q	-0.46%
Shares Yo Y	11.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 101.6M
Average Volume	181,663.35x
Bv Per Share	12.79
CAPEX	TWD -6.2M
Ch1m	-8.51
Ch1w	-7.26
Ch1y	-38.94
Ch3m	-27.63
Ch3y	8.88
Ch5y	-25.52
Ch6m	-34.51
Change	-1.13%
Change From Open	-1.13
Close	31
Days Gap	0
Depreciation Amortization	16,708,000
Dollar Volume	5,685,513.7
Earnings Date	2026-08-11
EBIT	TWD 41.5M
EBITDA	TWD 58.2M
EPS	TWD 0.84
F Score	6
FCF	TWD 104.7M
FCF EV Yield	5.33x
FCF Per Share	TWD 1.36
Financing CF	-94,572,000
Fiscal Year End	December
Founded	2,014
Graham Number	15.54713
Graham Upside	-49.28
Income Tax	TWD -14.2M
Investing CF	-55,006,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	42.46
Ma150ch	-27.81%
Ma20	32.52
Ma20ch	-5.74%
Net CF	-38,673,000
Next Earnings Date	2026-08-11
Open	31
P FCF Ratio	22.86
P OCF Ratio	21.59
Payment Date	2025-07-30
Position In Range	65.79
Ppne	59,821,000
Price Date	2026-05-08
Price EBITDA	TWD 41.16
Ptbv Ratio	2.63
Relative Volume	1.08x
Revenue	206,735,000x
SBC By Revenue	1.53x
Share Based Comp	3,163,000
Tax By Revenue	-6.88x
Tr6m	-34.51%
Volume	185,498
Z Score	24.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6808 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$0.10 annual per share

Payout ratio

+62.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-11.6%

Dividend yield + buyback yield combined

Performance

TPEX/6808 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6808?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.2%

Share of float held by funds and institutions

Insider ownership

+27.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.9%

Negative means the company is buying back shares.

Technical

TPEX/6808 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

-30.2%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6808

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6808 stock rating?

tpex/6808 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6808 analysis?

The full report lives at /stocks/tpex/6808/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6808?

The latest report frames tpex/6808 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6808 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.